A citation-based method for searching scientific literature


List of co-cited articles
379 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
Manabu Soda, Young Lim Choi, Munehiro Enomoto, Shuji Takada, Yoshihiro Yamashita, Shunpei Ishikawa, Shin-ichiro Fujiwara, Hideki Watanabe, Kentaro Kurashina, Hisashi Hatanaka,[...]. Nature 2007
32

Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non-small-cell lung cancer.
Jianya Zhou, Hongtian Yao, Jing Zhao, Shumeng Zhang, Qihan You, Ke Sun, Yinying Zou, Caicun Zhou, Jianying Zhou. Histopathology 2015
26
50

Detection of ALK-positive non-small-cell lung cancers on cytological specimens: high accuracy of immunocytochemistry with the 5A4 clone.
Spasenija Savic, Beata Bode, Joachim Diebold, Ivo Tosoni, Audrey Barascud, Betty Baschiera, Bruno Grilli, Michelle Herzog, Ellen Obermann, Lukas Bubendorf. J Thorac Oncol 2013
72
30

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
Benjamin J Solomon, Tony Mok, Dong-Wan Kim, Yi-Long Wu, Kazuhiko Nakagawa, Tarek Mekhail, Enriqueta Felip, Federico Cappuzzo, Jolanda Paolini, Tiziana Usari,[...]. N Engl J Med 2014
27

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Eunice L Kwak, Yung-Jue Bang, D Ross Camidge, Alice T Shaw, Benjamin Solomon, Robert G Maki, Sai-Hong I Ou, Bruce J Dezube, Pasi A Jänne, Daniel B Costa,[...]. N Engl J Med 2010
25

Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.
Leilei Liu, Ping Zhan, Xiaodie Zhou, Yong Song, Xiaojun Zhou, Like Yu, Jiandong Wang. PLoS One 2015
28
39

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
Alice T Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De Pas, Benjamin Besse, Benjamin J Solomon, Fiona Blackhall,[...]. N Engl J Med 2013
23

An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators.
Murry W Wynes, Lynette M Sholl, Manfred Dietel, Ed Schuuring, Ming S Tsao, Yasushi Yatabe, Raymond R Tubbs, Fred R Hirsch. J Thorac Oncol 2014
119
23

ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.
Greta Alì, Agnese Proietti, Serena Pelliccioni, Cristina Niccoli, Cristiana Lupi, Elisa Sensi, Riccardo Giannini, Nicla Borrelli, Maura Menghi, Antonio Chella,[...]. Arch Pathol Lab Med 2014
70
23


Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Marina Pekar-Zlotin, Fred R Hirsch, Lior Soussan-Gutman, Maya Ilouze, Addie Dvir, Theresa Boyle, Murry Wynes, Vincent A Miller, Doron Lipson, Gary A Palmer,[...]. Oncologist 2015
110
20

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
Alice T Shaw, Beow Y Yeap, Mari Mino-Kenudson, Subba R Digumarthy, Daniel B Costa, Rebecca S Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott,[...]. J Clin Oncol 2009
18

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
D Ross Camidge, Yung-Jue Bang, Eunice L Kwak, A John Iafrate, Marileila Varella-Garcia, Stephen B Fox, Gregory J Riely, Benjamin Solomon, Sai-Hong I Ou, Dong-Wan Kim,[...]. Lancet Oncol 2012
891
16

Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances.
Florian Cabillic, Audrey Gros, Frédéric Dugay, Hugues Begueret, Laura Mesturoux, Dan Cristian Chiforeanu, Leila Dufrenot, Vincent Jauffret, Dominique Dachary, Romain Corre,[...]. J Thorac Oncol 2014
128
16

The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.
Bryan L Betz, Catherine A Dixon, Helmut C Weigelin, Stewart M Knoepp, Michael H Roh. Cancer Cytopathol 2013
48
16


ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.
Antonio Marchetti, Alessia Di Lorito, Maria Vittoria Pace, Manuela Iezzi, Lara Felicioni, Tommaso D'Antuono, Giampaolo Filice, Luigi Guetti, Felice Mucilli, Fiamma Buttitta. J Thorac Oncol 2016
89
16


Immunohistochemistry practices of cytopathology laboratories: a survey of participants in the College of American Pathologists Nongynecologic Cytopathology Education Program.
Andrew H Fischer, Mary R Schwartz, Ann T Moriarty, David C Wilbur, Rhona Souers, Lisa Fatheree, Christine N Booth, Amy C Clayton, Daniel F I Kurtyz, Vijayalakshmi Padmanabhan,[...]. Arch Pathol Lab Med 2014
31
22

ALK status testing in non-small-cell lung carcinoma by FISH on ThinPrep slides with cytology material.
Eugen C Minca, Christopher P Lanigan, Jordan P Reynolds, Zhen Wang, Patrick C Ma, Joseph Cicenia, Francisco A Almeida, Nathan A Pennell, Raymond R Tubbs. J Thorac Oncol 2014
39
17

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.
Xiaoqing Liu, Yachao Lu, Guanshan Zhu, Yao Lei, Li Zheng, Haifeng Qin, Chuanhao Tang, Gillian Ellison, Rose McCormack, Qunsheng Ji. J Clin Pathol 2013
116
16

Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.
Spasenija Savic, Joachim Diebold, Anne-Katrin Zimmermann, Wolfram Jochum, Betty Baschiera, Susanne Grieshaber, Luigi Tornillo, Bettina Bisig, Keith Kerr, Lukas Bubendorf. Lung Cancer 2015
59
16

Testing for ROS1 in non-small cell lung cancer: a review with recommendations.
Lukas Bubendorf, Reinhard Büttner, Fouad Al-Dayel, Manfred Dietel, Göran Elmberger, Keith Kerr, Fernando López-Ríos, Antonio Marchetti, Büge Öz, Patrick Pauwels,[...]. Virchows Arch 2016
114
16

ALK rearrangements in EBUS-derived transbronchial needle aspiration cytology in lung cancer.
M J Neat, N J Foot, A Hicks, R Breen, B Wilkins, E McLean, G Santis. Cytopathology 2013
37
16

Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.
Agnese Proietti, Greta Alì, Serena Pelliccioni, Cristiana Lupi, Elisa Sensi, Laura Boldrini, Adele Servadio, Antonio Chella, Alessandro Ribechini, Federico Cappuzzo,[...]. Cancer Cytopathol 2014
32
18

Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement.
Ling Shan, Fang Lian, Lei Guo, Xin Yang, Jianming Ying, Dongmei Lin. Diagn Pathol 2014
30
20

ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH.
Eugen C Minca, Bryce P Portier, Zhen Wang, Christopher Lanigan, Carol F Farver, Yan Feng, Patrick C Ma, Valeria A Arrossi, Nathan A Pennell, Raymond R Tubbs. J Mol Diagn 2013
92
13

Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent.
Chris M J Conklin, Kenneth J Craddock, Cherry Have, Janessa Laskin, Christian Couture, Diana N Ionescu. J Thorac Oncol 2013
154
13

Multiplexed molecular profiling of lung cancer using pleural effusion.
Hiroaki Akamatsu, Yasuhiro Koh, Hirotsugu Kenmotsu, Tateaki Naito, Masakuni Serizawa, Madoka Kimura, Keita Mori, Hisao Imai, Akira Ono, Takehito Shukuya,[...]. J Thorac Oncol 2014
26
23

Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.
Maximilian von Laffert, Arne Warth, Roland Penzel, Peter Schirmacher, Keith M Kerr, Göran Elmberger, Hans-Ulrich Schildhaus, Reinhard Büttner, Fernando Lopez-Rios, Simone Reu,[...]. J Thorac Oncol 2014
55
13

A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material.
John Le Quesne, Manisha Maurya, Slaveya G Yancheva, Mary O'Brien, Sanjay Popat, Andrew C Wotherspoon, David Gonzalez de Castro, Andrew G Nicholson. J Thorac Oncol 2014
36
16

ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas.
Lynette M Sholl, Heather Sun, Mohit Butaney, Chengsheng Zhang, Charles Lee, Pasi A Jänne, Scott J Rodig. Am J Surg Pathol 2013
115
13

Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry.
Esther Conde, Ana Suárez-Gauthier, Amparo Benito, Pilar Garrido, Rosario García-Campelo, Michele Biscuola, Luis Paz-Ares, David Hardisson, Javier de Castro, M Carmen Camacho,[...]. PLoS One 2014
50
13

Young investigator challenge: Validation and optimization of immunohistochemistry protocols for use on cellient cell block specimens.
Jennifer L Sauter, Karen L Grogg, Julie A Vrana, Mark E Law, Jennifer L Halvorson, Michael R Henry. Cancer Cytopathol 2016
43
13

Principles of analytic validation of immunohistochemical assays: Guideline from the College of American Pathologists Pathology and Laboratory Quality Center.
Patrick L Fitzgibbons, Linda A Bradley, Lisa A Fatheree, Randa Alsabeh, Regan S Fulton, Jeffrey D Goldsmith, Thomas S Haas, Rouzan G Karabakhtsian, Patti A Loykasek, Monna J Marolt,[...]. Arch Pathol Lab Med 2014
155
13

ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients.
Cecilia Bozzetti, Rita Nizzoli, Marcello Tiseo, Anna Squadrilli, Costanza Lagrasta, Sebastiano Buti, Donatello Gasparro, Daniele Zanoni, Maria Majori, Massimo De Filippo,[...]. Diagn Cytopathol 2015
37
16


Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.
Sinchita Roy-Chowdhuri, Dara L Aisner, Timothy Craig Allen, Mary Beth Beasley, Alain Borczuk, Philip T Cagle, Vera Capelozzi, Sanja Dacic, Gilda da Cunha Santos, Lida P Hariri,[...]. Arch Pathol Lab Med 2016
60
13

Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Alice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, D Ross Camidge, Benjamin J Solomon, Ravi Salgia, Gregory J Riely, Marileila Varella-Garcia, Geoffrey I Shapiro, Daniel B Costa,[...]. N Engl J Med 2014
13


EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
J Guillermo Paez, Pasi A Jänne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon,[...]. Science 2004
11

ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA.
S Bravaccini, M M Tumedei, P Ulivi, W Zoli, D Calistri, P Candoli, D Amadori, M Puccetti. Cytopathology 2016
16
31

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
Tony S Mok, Yi-Long Wu, Sumitra Thongprasert, Chih-Hsin Yang, Da-Tong Chu, Nagahiro Saijo, Patrapim Sunpaweravong, Baohui Han, Benjamin Margono, Yukito Ichinose,[...]. N Engl J Med 2009
11


Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.
Scott J Rodig, Mari Mino-Kenudson, Sanja Dacic, Beow Y Yeap, Alice Shaw, Justine A Barletta, Hannah Stubbs, Kenny Law, Neal Lindeman, Eugene Mark,[...]. Clin Cancer Res 2009
480
11

EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR.
Shang-Gin Wu, Yao-Wen Kuo, Yih-Leong Chang, Jin-Yuan Shih, Ya-Hui Chen, Meng-Feng Tsai, Chong-Jen Yu, Chih-Hsin Yang, Pan-Chyr Yang. J Thorac Oncol 2012
78
11

High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas.
Ping-Li Sun, Yan Jin, Hyojin Kim, Choon-Taek Lee, Sanghoon Jheon, Jin-Haeng Chung. Cancer Cytopathol 2013
46
11

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. J Thorac Oncol 2013
542
11

Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA Analysis.
Yi-Lin Chen, Chung-Ta Lee, Cheng-Chan Lu, Shu-Ching Yang, Wan-Li Chen, Yang-Cheng Lee, Chung-Hsien Yang, Shu-Ling Peng, Wu-Chou Su, Nan-Haw Chow,[...]. PLoS One 2016
13
38

Anaplastic Lymphoma Kinase Immunocytochemistry on Cell-Transferred Cytologic Smears of Lung Adenocarcinoma.
Chen Zhang, Melissa L Randolph, Kelly J Jones, Harvey M Cramer, Liang Cheng, Howard H Wu. Acta Cytol 2015
11
45


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.